Skip to main content

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Weekly Wrap 6 December

Bell Direct
December 6, 2024

Morning Bell 6 December

Bell Direct
December 6, 2024

Morning Bell 5 December

Bell Direct
December 5, 2024

Morning Bell 4 December

Grady Wulff
December 4, 2024

Morning Bel 3 December

Sophia Mavridis
December 3, 2024

Morning Bell 2 December

Grady Wulff
December 2, 2024

Weekly Wrap 29 November

Bell Direct
November 29, 2024

Morning Bell 28 November

Bell Direct
November 28, 2024

Morning Bell 27 November

Bell Direct
November 27, 2024

Morning Bell 26 November

Bell Direct
November 26, 2024

Morning Bell 25 November

Bell Direct
November 25, 2024

From the helm: Bega Cheese

Grady Wulff
November 22, 2024